Viz.ai Receives FDA 510(k) Clearance for Artificial Intelligence Algorithm for the Quantification of Intracerebral Hemorrhage

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its algorithm, Viz ICH Plus, intended to automate the process of...

Related Keywords

United States ,Jayme Strauss ,Peter Kan ,Department Of Neurosurgery ,Drug Administration ,Product Service ,University Of Texas Medical Branch ,Artificial Intelligence Algorithm ,Texas Medical ,